ArticleJCO precision oncology2022

ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.

Margherita Ambrosini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.